Drug Fix: Alzheimer’s Drugs, US FDA’s New Patient Info Leaflet, COVID-19 Vaccine Harmonization

Pink Sheet reporters and editors discuss CMS’s latest coverage announcement for Alzheimer’s drugs and the VA’s approach to the issue (0:29), the FDA’s new one-page patient medication information document (15:55), international convergence on COVID-19 vaccine strain selection (24:48), and Novavax’s place in the vaccine toolbox going forward (28:21). Read More In The Pink Sheet Medicare Registry Plan For Alzheimer’s Drugs Pairs CMS Web Portal With Health System Efforts https://pink.pharmaintelligence.informa.com/PS148313/Medicare-Registry-Plan-For-Alzheimers-Drugs-Pairs-CMS-Web-Portal-With-Health-System-Efforts The US VA And Alzheimer’s: A Misunderstood Decision https://pink.pharmaintelligence.informa.com/PS148214/The-US-VA-And-Alzheimers-A-Misunderstood-Decision One-Page Patient Medication Information Document Moves Forward Under Proposed Rule https://pink.pharmaintelligence.informa.com/PS148298/One-Page-Patient-Medication-Information-Document-Moves-Forward-Under-Proposed-Rule International Regulators Focus On Omicron XBB For Monovalent COVID-19 Vaccine https://pink.pharmaintelligence.informa.com/PS148301/International-Regulators-Focus-On-Omicron-XBB-For-Monovalent-COVID-19-Vaccine Novavax Readying Multiple COVID-19 Vaccine Candidates To Ensure Fall Availability https://pink.pharmaintelligence.informa.com/PS148261/Novavax-Readying-Multiple-COVID-19-Vaccine-Candidates-To-Ensure-Fall-Availability